Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets close in 3 hours 41 minutes

S&P 500
5,894.93
+24.31(+0.41%)
Dow 30
43,418.11
-26.88(-0.06%)
Nasdaq
18,804.19
+124.06(+0.66%)
Russell 2000
2,316.90
+13.07(+0.57%)
Crude Oil
68.82
+1.80(+2.69%)
Gold
2,613.70
+43.60(+1.70%)

Abingdon Health Plc (ABDX.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)

Follow

7.75

0.00

(0.00%)

At close: 04:28PM GMT

Currency in GBp

Valuation Measures⁴

Market Cap (intraday)	14.69M
Enterprise Value	14.30M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	3.89
Price/Book (mrq)	6.53
Enterprise Value/Revenue	2.33
Enterprise Value/EBITDA	-0.25

Trading Information

Stock Price History

Beta (5Y Monthly)	0.21
52-Week Change ³	-23.65%
S&P500 52-Week Change ³	29.10%
52 Week High ³	13.00
52 Week Low ³	6.50
50-Day Moving Average ³	8.75
200-Day Moving Average ³	9.59

Share Statistics

Avg Vol (3 month) ³	138.67k
Avg Vol (10 day) ³	156.68k
Shares Outstanding ⁵	189.52M
Implied Shares Outstanding ⁶	189.52M
Float ⁸	132.14M
% Held by Insiders ¹	48.89%
% Held by Institutions ¹	33.47%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends	Jun 30, 2024
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	-20.72%
Operating Margin (ttm)	-3.81%

Management Effectiveness

Return on Assets (ttm)	-17.93%
Return on Equity (ttm)	-48.69%

Income Statement

Revenue (ttm)	6.13M
Revenue Per Share (ttm)	0.02
Quarterly Revenue Growth (yoy)	27.00%
Gross Profit (ttm)	N/A
EBITDA	-1.25M
Net Income Avi to Common (ttm)	-1.27M
Diluted EPS (ttm)	-0.00
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	1.44M
Total Cash Per Share (mrq)	0
Total Debt (mrq)	1.05M
Total Debt/Equity (mrq)	46.64%
Current Ratio (mrq)	1.95
Book Value Per Share (mrq)	0.01

Cash Flow Statement

Operating Cash Flow (ttm)	-1.66M
Levered Free Cash Flow (ttm)	-1.52M